ESRP1 and pancreatic ductal adenocarcinoma: This is in agreement to pancreatic ductal adenocarcinoma where increased ESRP1 expression was related to better survival [18], but in contrast to breast cancer patients where ESRP1 was associated with lower survival rate [16].